Impact of Current Smoking in the Tolerance of Bronchoscopy

Smokers Clinical Trial

Official title:

Impact of Current Smoking in the Tolerance of Bronchoscopy

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01345383
• Other study ID #: AK/10-05-3898/38
• Status: Terminated
• Phase: N/A
• First received: April 28, 2011
• Last updated: March 9, 2015
• Start date: June 2010
• Est. completion date: August 2013

Study information

• Verified date: March 2015
• Source: Centre Hospitalier Universitaire Saint Pierre
• Contact: n/a
• Is FDA regulated: No
• Health authority: Belgium: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to study the impact of smoking in the preceding hours before a bronchoscopy on the tolerance of this exam.

Description:

Tolerance evaluation of the bronchoscopy on current and regular smokers. The investigators assess episodes of cough, dyspnea, volume of lidocain (liquid 1% and in spray 10%), duration of the procedure, episodes of desaturation and completion of the bronchoscopy.

The investigators compare patients who did not smoke in the 6 hours before the bronchoscopy and those who have smoked.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 100
• Est. completion date: August 2013
• Est. primary completion date: August 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• current and regular smoker

• bronchoscopy under local anesthesia

Exclusion Criteria:

• patients needing EBUS or fluoroscopy

• intravenous sedative

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Smokers

Intervention

Procedure:
• bronchoscopy
Routine bronchoscopy under local anesthesia (lidocain). Duration: +/- 10 min

Locations

Country	Name	City	State
Belgium	CHU Saint Pierre	Brussels

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire Saint Pierre

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	cough	number of cough episodes during the bronchoscopy	Day 1	No
Secondary	dyspnea	dyspnea evaluation before and during the bronchoscopy	day 1	No
Secondary	Lidocaine volume	Volume of local anesthesic needed during bronchoscopy	day 1	No
Secondary	length of bronchoscopy	length of bronchoscopy	Day 1	No
Secondary	desaturation episodes	desaturation episodes during bronchoscopy	day 1	No